---
category: news
title: "Athos Therapeutics Announces the Completion of its Oversubscribed Series A Financing"
excerpt: "Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with autoimmune diseases and cancer, announced today the completion of an oversubscribed"
publishedDateTime: 2021-11-15T16:47:00Z
originalUrl: "https://www.lelezard.com/en/news-20104281.html"
webUrl: "https://www.lelezard.com/en/news-20104281.html"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Le LÃ©zard
  domain: lelezard.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.lelezard.com/img/pr_sections/health.jpg"
    width: 640
    height: 480
    isCached: true

secured: "85GJfM9WZ+3T/sdHLL88JghOp9k8zFi59UuItoKl3XbVp3zzy6uj2GZGbbPmQ15pXypzsJCehnNtNfcigRvjRHrhtTw+TtbaVpPKhK0yYJYhiiKt1DxlvpsuckClY5/ARCJPopjaklMVgz0rXP/NjxUDSNh3zMpFLhIPUA6usRVVRDKkB3PBb912sfKKvhVUR+v0x0/VB+7YbTel0hU2RwGlk2wiak531eQqsZBn/QSIi7yruAAd90g48tW8tkjmTBW40kh6I3SSYiVllt8rtXbDLrz5Ttr/VKa3dz8AJNlEKlNYL9Kkf7L42rmfKk5TS9NEVfICMI7EET2jbNxqIoEtxzK/dVzLxm6VESzja4g=;vNLuEMlRANCIudomK7dxKQ=="
---

